Metformin pharmacogenomics: current status and future directions

The incidence of type 2 diabetes (T2D) and its costs to the health care system continue to rise. Despite the availability of at least 10 drug classes for the treatment of T2D, metformin remains the most widely used first-line pharmacotherapy for its treatment; however, marked interindividual variabi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) Jg. 63; H. 8; S. 2590
Hauptverfasser:	Pawlyk, Aaron C, Giacomini, Kathleen M, McKeon, Catherine, Shuldiner, Alan R, Florez, Jose C
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.08.2014
Schlagworte:	Adolescent Adult Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - genetics Gene Expression Regulation Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - metabolism Hypoglycemic Agents - therapeutic use Metformin - adverse effects Metformin - metabolism Metformin - therapeutic use Pharmacogenetics
ISSN:	1939-327X, 1939-327X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!